CoreCap Advisors, LLC

Position in GILD — Gilead Sciences, Inc.

CIK 1902501 SOUTHFIELD, MI

Position in GILD

as of Jun 30, 2026 · filed Jul 6, 2026 Compact

Position Value

$5,890,476

+$94,775 QoQ

Shares Held

46,624

+12.1% QoQ

Ownership

0.004%

of shares outstanding

% of Portfolio

0.55%

of 13F equity value

Holder Rank

#132

of 913 holders

Holding Since

Dec 2021

14 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

CoreCap Advisors, LLC holds $42,526,097 across 17 Drug Manufacturers - General names. GILD ranks #3 (13.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson	47,921	$12,170,496
2	MRK	Merck & Co., Inc.	61,485	$7,900,822
3	GILD	Gilead Sciences, Inc. This page	46,624	$5,890,476
4	ABBV	AbbVie Inc.	20,967	$5,276,135
5	LLY	ELI LILLY & Co	3,816	$4,577,025
6	AMGN	Amgen Inc	5,755	$2,084,000
7	PFE	Pfizer Inc	85,905	$2,068,592
8	BMY	Bristol Myers Squibb Co	24,801	$1,429,033

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$5,890,476	46,624	+12.1%	Shares	Sole	2026-07-06
2026-03-31	$5,795,701	41,585	+2670.5%	Shares	Sole	2026-04-07
2025-12-31	$184,232	1,501	-25.5%	Shares	Sole	2026-01-13
2025-09-30	$223,665	2,015	-72.4%	Shares	Sole	2025-10-22
2025-06-30	$809,461	7,301	+11.5%	Shares	Sole	2025-08-14
2025-03-31	$733,703	6,548	-73.5%	Shares	Sole	2025-05-09
2024-12-31	$2,278,583	24,668	+2295.0%	Shares	Sole	2025-02-14
2024-09-30	$86,355	1,030	-45.2%	Shares	Sole	2024-11-08
2024-03-31	$137,710	1,880	-72.6%	Shares	Sole	2024-08-08
2023-06-30	$528,777	6,861	+216.9%	Shares	Sole	2024-01-16
2022-12-31	$185,865	2,165	-91.5%	Shares	Sole	2023-02-10
2022-09-30	$1,571,614	25,476	+1812.6%	Shares	Sole	2023-02-10
2022-06-30	$82,330	1,332	+49.3%	Shares	Sole	2022-08-11
2021-12-31	$64,768	892	—	Shares	Sole	2022-02-10
No filing history on record for this holder in this stock.